Comparison between methotrexate and apremilast in Psoriatic Arthritis-a single blind randomized controlled trial (APREMEPsA study)

To compare the efficacy of methotrexate and apremilast in psoriatic arthritis (PsA). This Single blinded (physician), parallel group, randomized controlled trial was conducted at a single centre between October 2019 and December 2020. Adult PsA patients (age > 18 years), fulfilling CASPAR criteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Samanta, Joydeep, Naidu, GSRSNK, Chattopadhyay, Arghya, Basnet, Amal, Narang, Tarun, Dhir, Varun, Dogra, Sunil, Jain, Sanjay, Sharma, Aman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037372/
https://www.ncbi.nlm.nih.gov/pubmed/36961603
http://dx.doi.org/10.1007/s00296-023-05315-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037372/
https://www.ncbi.nlm.nih.gov/pubmed/36961603
http://dx.doi.org/10.1007/s00296-023-05315-4

Ejemplares similares